Methamphetamine and other ATS remain the leading substances for which people seek drug treatment in East and South-East Asia.The number of people receiving treatment for ATS use, mainly methamphetamine, has remained stable or declined in the majority of reporting countries – with the exception of…
The synthetic drugs market in the Near and Middle East remains dynamic, following disruptions in the supply of “captagon”.The Near and Middle East accounted for 77 per cent of global “captagon” seizures in 2020–2024, with production mainly in the Syrian Arab Republic and Lebanon and trafficking…
Asia has increasingly become a transit and destination region for cocaine trafficking and use over the past decade, although the growth in indicators of availability and use is moderate.Cocaine seizures in Asia increased more than sixfold between 2015 and 2024. Additionally, the number of seizures…
Seizures of methamphetamine in Asia continue to rise, even as the reported number of dismantled methamphetamine laboratories declines.Methamphetamine seizures in Asia reached a record high in 2024, while the number of dismantled (and reported) methamphetamine laboratories declined to its lowest…
Seizures of methamphetamine continued rising in South-East Asia while declining in East Asia.The largest quantities of methamphetamine worldwide were seized in East and South-East Asia, accounting for 48 per cent of the world’s total in 2024.Seizures of methamphetamine have been declining over the…
Methamphetamine seizures now dominate overall seizures of amphetamine-type stimulants (ATS) in the Near and Middle East/South-West Asia.Until 2022, ATS seizures in the subregion were dominated by amphetamine – notably “captagon” – but methamphetamine seizures have continued to rise since while…
